Download Free Sample Report

The global BRAHMS Procalcitonin (PCT) market size was valued at US$ 1.23 billion in 2024 and is projected to reach US$ 1.89 billion by 2030, at a CAGR of 7.4% during the forecast period 2024-2030.
The United States BRAHMS Procalcitonin (PCT) market size was valued at US$ 345.6 million in 2024 and is projected to reach US$ 512.3 million by 2030, at a CAGR of 6.8% during the forecast period 2024-2030.
BRAHMS Procalcitonin (PCT) is a biomarker test used for early detection and monitoring of bacterial infections and sepsis, helping in antibiotic stewardship.
The global BRAHMS PCT market is experiencing strong growth, driven by increasing focus on sepsis management. In 2023, total test volume reached 89 million, with hospital settings accounting for 70% of demand. The emergency care segment is growing at 8.5% annually. The market saw a 25% increase in demand for automated testing platforms in 2023. Traditional PCT assays dominate with a 65% market share, while point-of-care tests are growing at 12% annually. North America leads with a 40% market share, while Asia Pacific is the fastest-growing region at 9.0% CAGR. The industry is focusing on developing rapid testing solutions, with a 30% growth in R&D investments.
Report Overview BRAHMS Procalcitonin (PCT) refers to a biomarker used in the diagnosis and management of bacterial infections and sepsis. This report provides a deep insight into the global BRAHMS Procalcitonin (PCT) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc. The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global BRAHMS Procalcitonin (PCT) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market. In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the BRAHMS Procalcitonin (PCT) market in any manner. Global BRAHMS Procalcitonin (PCT) Market: Market Segmentation Analysis The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments. Key Company Thermo Fisher Roche Diagnostics bioMerieux Siemens Samsung Abbott Fujirebio Market Segmentation (by Type) Procalcitonin Antigen Procalcitonin Antibody Market Segmentation (by Application) Medical Industry Veterinarian Scientific Research Geographic Segmentation